Am J Transplant, Volume 18, Suppl 3 Archives - Page 33 of 211 - ATC Abstracts

2018 American Transplant Congress
Cost Analysis of Loco-Regional Bridging Therapy for Hepatocellular Carcinoma: A National Study
M. Nazzal,¹ R. Ouseph,¹ X. Huiling,¹ M. Schnitzler,¹ C. Varma,¹ H. Randall,¹ J. Tuttle-Newhall,² D. Axelrod,³ K. Lentine.¹
¹Abdominal Transplant, Saint Louis University Hospital, Saint Louis, MO; ²Surgery, East Carolina University/Brody School of Medicine, Greenville, NC.
Liver transplantation (LT) is cost-effective in the primary treatment of Hepatocellular carcinoma (HCC). Loco-regional therapies (LRTs) have increased as both primary therapy for HCC as…
2018 American Transplant Congress
Vascular Invasion and Survival after Liver Transplantation for Hepatocellular Carcinoma: A Study from the European Liver Transplant Registry
H-.C. Pommergaard, A. Rostved, R. Adam, L. Thygesen, M. Salizzoni, M. Bravo, D. Cherqui, F. Filipponi, K. Boudjema, V. Mazzaferro, O. Soubrane, J. García-Valdecasas, J. Prous, A. Pinna, J. O'Grady, V. Karam, C. Duvoux, A. Rasmussen.
Rigshospitalet, Copenhagen, Denmark; Rigshospitalet, Copenhagen, Denmark; Hôpital Universitaire Paul Brousse, Villejuif, France; National Institute of Public Health, Copenhagen, Denmark; A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy; Hospital Virgen del Rocio, Sevilla, Spain; Hôpital Universitaire Paul Brousse, Villejuif, France; University of Pisa Medical School Hospital, Pisa, Italy; Hôpital Pontchaillou, Rennes, France; Istituto Nazionale Tumori, Milan, Italy; Beaujon Hospital, Clichy, France; Hospital Clínic, Barcelona, Spain; Hospital Universitari de Bellvitge, Barcelona, Spain; S. Orsola Hospital, Bologna, Italy; King's College Hospital, London, United Kingdom; Hôpital Universitaire Paul Brousse, Villejuif, France; Henri Mondor Hospital, Créteil, France; Rigshospitalet, Copnehagen, Denmark.
PurposeStudies suggest that vascular invasion may be a superior prognostic marker compared with traditional selection criteria, e.g. Milan criteria. We aimed to investigate the prognostic…
2018 American Transplant Congress
Digital Health Education for the Pediatric Solid Organ Transplant Population
T. Nemeth,¹ J. Smith,² A. Pollack,² W. Swanson,³ E. Hsu.⁴
¹Pharmacy, Seattle Children's, Seattle; ²Nephrology, University of Washington, Seattle; ³Digital Health, Seattle Children's, Seattle; ⁴Hepatology, University of Washington, Seattle.
Background: Self-management and adherence are key factors that influence post transplant graft survival. Education after solid organ transplant plays an important role in providing patients…
2018 American Transplant Congress
Willingness to Accept HIV-Positive and Increased Infectious Risk Donor Organs among HIV-Positive Transplant Candidates
M. Waldram, A. Eno, E. Lee, S. Seaman, A. Nguyen, S. Halpern, S. Anjum, J. Sugarman, M. Henderson, A. Tobian, D. Segev, C. Durand.
JHU, Baltimore.
Implementation of HIV+ to HIV+ organ transplantation under the HOPE Act could shorten waitlist times for HIV+ transplant candidates. However, realizing these potential benefits depends…
2018 American Transplant Congress
Organ Transplant Abuse in China (1): Scale
G. Yin,¹ D. Li,¹ M. Li,¹ M. Fu.²
¹China Organ Harvest Research Center, Middletown, NY; ²MD Anderson Cancer Center, University of Texas, Houston, TX.
Background and PurposeIn 2006, allegations emerged that the People's Republic of China has been harvesting organs from prisoners of conscience in extrajudicial killings on a…
2018 American Transplant Congress
Perceptions, Motivations, and Concerns about Living Organ Donation among People Living with HIV
S. Rasmussen, M. Henderson, J. Bollinger, S. Seaman, C. Durand, D. Segev, J. Sugarman.
JHU, Baltimore.
Background: The HIV Organ Policy Equity (HOPE) Act permits persons living with HIV (PLWH) to donate organs within research protocols. Motivations and concerns related to…
2018 American Transplant Congress
Post-Transplant Lymphoproliferative Disorder after Kidney Transplantation: A Single Institute Experience with Focus on Epstein-Barr Virus Status
P. Zhang,¹ R. King,¹ K. Ristow,² L. Cornell,¹ F. Cosio,³ T. Habermann,² M. Alexander.¹
¹Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; ²Divsion of Hematology and Oncology, Mayo Clinic, Rochester, MN; ³Divsion of Nephrology and Hypertension, Mayo Clinic, Rochester, MN.
Background: Comparing to other types of solid organ transplant, the Post-Transplant Lymphopro- liferative Disorder (PTLD) in kidney transplant recipients (KTRs) is relatively rare. Due to…
2018 American Transplant Congress
The Chauvet Workgroup: From Inception to the Future
H. Amer,¹ S. Jowsey-Gregoire,¹ M. Kumnig,² E. Moreno,³ W. Dean,⁴ C. Brown,⁵ S. Jarvholm,⁶ K. Coffman,⁷ P. Petruzzo,⁸ E. Morelon.⁸
¹Mayo Clinic, Rochester, MN; ²University of Innsbruck, Innsbruck, Austria; ³UCLA, Los Angeles, CA; ⁴US Department of Defense, Fort Detrick, MD; ⁵University of Pittsburgh, Pittsburgh, PA; ⁶University of Gothenburg, Gothenburg, Sweden; ⁷Cleveland Clinic, Cleveland, OH; ⁸University of Lyon, Lyon, France.
From the first hand transplant that ushered in the era of reconstructive transplantation, it was apparent that the psychosocial background of the patient and the…
2018 American Transplant Congress
Shared Genetic Ancestry as a Predictor of Medium Term Renal Transplant Outcome in Deceased Donor Transplants
C. Stapleton,¹ On behalf of the UK and Ireland Renal Transplant Consortium, P. Conlon,² G. Cavalleri.¹
¹Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland; ²Department of Nephrology, Beaumont Hospital, Dublin, Ireland.
Sibling transplant pairs have better transplant outcomes than unrelated donor recipient (DR) pairs indicating that shared genetic ancestry between donors and recipients can aid in…
2018 American Transplant Congress
Sub-Clinical Acute Rejection (subAR) Detected by Both Surveillance Biopsy (SBx) and a Peripheral Blood Molecular Biomarker Correlates with De Novo Donor Specific Antibody (dnDSA) Following Kidney Transplant (KT)
R. Heilman,¹ J. Friedewald,² K. Kurian,⁵ T. Whisemant,⁵ E. Poggio,³ C. Marsh,⁵ P. Baliga,⁷ N. Bridges,⁴ J. Odim,⁴ M. Brown,⁴ D. Ikle,³ B. Armstrong,³ L. Zhao,² D. Salomon,⁵ M. Abecassis.²
¹Mayo Clinic, Phoenix; ²Northwestern University, Chicago; ³Rho Federal Systems, Chapel Hill; ⁴National Institute of Allergy and Infectious Disease, Bethesda; ⁵Scripps Health, La Jolla; ⁶Cleveland Clinic, Cleveland; ⁷Medical University of South Carolina, Charleston.
AIMWe investigated the correlation between subAR diagnosed by SBx or by a newly-defined biomarker, and the development of dnDSA.METHODS307 KT patients enrolled into a multi-center…